Get an alert when RESOLUTION THERAPEUTICS LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£9.4m

-38% lowest in 3 filed years

Net assets

£12m

+56.4% highest in 3 filed years

Employees

60

-11.8% lowest in 3 filed years

Profit before tax

-£24m

-9.4% lowest in 3 filed years

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

3-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31

Metric Trend 2024-03-312025-03-312026-03-31 Δ vs prior
Turnover ——— —
Operating profit -£17,710,354-£22,053,399-£23,673,498 -7.3%
Profit before tax -£17,710,354-£22,291,205-£24,378,820 -9.4%
Net profit -£15,742,906-£20,467,910-£22,633,405 -10.6%
Cash £13,817,911£15,211,685£9,427,831 -38%
Total assets less current liabilities £4,050,368£7,569,356£11,835,776 +56.4%
Net assets £4,050,368£7,569,356£11,835,776 +56.4%
Equity £4,050,368£7,569,356£11,835,776 +56.4%
Average employees 706860 -11.8%
Wages £4,748,390£6,035,643£6,089,739 +0.9%
Directors' remuneration £423,857£856,011£859,845 +0.4%
Directors' pension contributions £13,067£37,868£24,337 -35.7%
Highest paid director £181,510£571,518£597,330 +4.5%

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-03-312025-03-312026-03-31
Return on capital employed -437.3%-291.4%-200.0%
Gearing (liabilities / total assets) 78.4%63.2%19.4%
Current ratio 1.14x1.43x4.56x
Interest cover —-43.10x-23.61x

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 1 time since incorporation

  1. RESOLUTION THERAPEUTICS LIMITED 2020-07-30 → present
  2. SYNCONA COLLABORATION (E) LIMITED 2017-12-14 → 2020-07-30

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Consolidated group
Auditor
RSM UK Audit LLP
Audit opinion
Unqualified (clean)
Going concern
Material uncertainty disclosed

“These conditions indicate the existence of a material uncertainty which may cast significant doubt about the company and group's ability to continue as a going concern, such that it may be unable to realise its assets and discharge its liabilities in the normal course of business.”

Group structure

  1. RESOLUTION THERAPEUTICS LIMITED · parent
    1. Resolution Therapeutics US LLC 100% · Delaware · provide strategic management services to Resolution Therapeutics Limited.

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

6 active · 4 resigned

Name Role Appointed Born Nationality
FORBES, Stuart John, Professor Director 2020-08-26 Dec 1967 British
GARCIA GAJARDO, Gonzalo Andres Director 2024-09-30 Mar 1989 British
HEFNI, Amir Director 2023-08-14 Jun 1979 British
HODGKIN, Edward Eliot Director 2017-12-14 Aug 1963 British
SEKHRI, Paul Jai Director 2024-10-23 Apr 1958 American
SYMONDS, William Thomas Director 2022-06-17 Sep 1967 American
Show 4 resigned officers
Name Role Appointed Resigned
BRADSHAW, John Director 2018-11-20 2020-08-26
BRIGHT, Lisa Jane Director 2021-01-19 2024-09-03
MURPHY, Martin Patrick, Dr Director 2020-08-26 2023-11-16
SYKES, Toby George Director 2017-12-14 2018-11-20

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Syncona Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2017-12-14 Active

Filing timeline

Last 20 of 85 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2025-04-16 RESOLUTIONS Resolution
Date Type Category Description
2026-09-22 AA accounts Accounts with accounts type group
2026-08-18 SH01 capital Capital allotment shares PDF
2026-06-17 SH01 capital Capital allotment shares PDF
2026-04-15 CS01 confirmation-statement Confirmation statement with updates PDF
2026-04-09 SH01 capital Capital allotment shares PDF
2026-03-25 RP01AP01 officers Replacement filing of director appointment with name PDF
2026-03-13 SH01 capital Capital allotment shares PDF
2026-02-10 RP01AP01 officers Replacement filing of director appointment with name PDF
2026-02-04 CH01 officers Change person director company with change date PDF
2026-01-30 CH01 officers Change person director company with change date PDF
2025-12-15 CH01 officers Change person director company with change date PDF
2025-11-07 AA accounts Accounts with accounts type group
2025-10-13 AD01 address Change registered office address company with date old address new address PDF
2025-06-12 SH06 capital Capital cancellation shares
2025-05-20 SH03 capital Capital return purchase own shares
2025-04-16 SH01 capital Capital allotment shares PDF
2025-04-16 RESOLUTIONS resolution Resolution
2025-01-31 CS01 confirmation-statement Confirmation statement with updates PDF
2025-01-20 SH06 capital Capital cancellation shares
2025-01-20 SH03 capital Capital return purchase own shares

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
13

last 12 months

Capital events
9

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page